HSP90 Inhibitor Protein
CNY 3580.00
货期*
7周
规格
| Cited in 4 publications. |
Product images
Specifications
| Product Data | |
| Predicted MW | 558.7 |
| Purity | >98% pure (TLC: 5% Methanol/Methylene Chloride, Rf=0.26). |
| Buffer | Presentation State: Purified State: Purple solid |
| Preparation | Purple solid |
| Protein Description | Red to dark red powder. CAS No: 75747-14-7 Formula: C31H43N3O8 |
| Storage | Upon receipt, store at -20°C. |
| Stability | Shelf life: one year from despatch. |
| Reference Data | |
| Synonyms | 17-AAG |
| Summary | Glendanamycin (GA), a benzoquinone ansamycin antibiotic, interferes with the action of Hsp90 leading to degradation of Hsp90 client proteins. GA itself however has undesirable properties such as poor aqueous solubility and liver toxicity; therefore, numerous analogs have been synthesized, such as 17-AAG(1). 17-AAG is an HSP-90 inhibitor that displays a 100-fold higher affinity for HSP-90 derived from tumor cells compared to HSP-90 from normal cells(2). 17- AAG inhibits Akt activation and expression in tumors and synergizes with a number of antitumor agents such as taxol(3), cisplatin(4) and UCN-01 (400 nM 17-AAG, U937 cells)(5). |
Citations (4)
| The use of this Proteins has been cited in the following citations: |
|---|
|
Tamoxifen therapy in a murine model of myotubular myopathy
,null,
Nature Communications
,PubMed ID 30451841
|
|
MicroRNA-644a promotes apoptosis of hepatocellular carcinoma cells by downregulating the expression of heat shock factor 1
,null,
Cell Communication and Signaling : CCS
,PubMed ID 29898735
|
|
Mutations in PIH1D3 Cause X-Linked Primary Ciliary Dyskinesia with Outer and Inner Dynein Arm Defects
,null,
American Journal of Human Genetics
,PubMed ID 28041644
|
|
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias
,null,
Blood
,PubMed ID 20651072
|
Documents
| FAQs |
| SDS |
Customer
Reviews
Loading...
